In 1929, when the Saskatchewan Medical Association created a Cancer Committee, the major achievement of the Committee was the establishment of the first government supported comprehensive provincial cancer control program in Canada. The report also proposed the establishment of a voluntary medical-lay Canadian Society for the Control of Cancer. As the comprehensive cancer control concept spread across Canada within the provinicial medical associations and provinicials governments, the Canadian Medical Association (CMA), represented by Dr. John S. McEachern, took up the cause of promoting such a voluntary cancer organization. Initially the idea developed slowly but, in 1935, gained momentum when the Governor General, the Earl of Bessborough, initiated The King George V Silver Jubilee Cancer Fund for Canada and financial support for such a project became a possibility. The focus of this paper is on McEachern's shepherding of the voluntary cancer society idea within the CMA and the convoluted path which led to the provision of financial support for the project by the Trustees of the King George V Cancer Fund. The Canadian Society of the Control of Cancer, later renamed the Canadian Cancer Society, was created by Letters Patent on 28 March 1938.

Download full-text PDF

Source
http://dx.doi.org/10.3138/cbmh.22.1.155DOI Listing

Publication Analysis

Top Keywords

cancer society
12
cancer
11
canadian cancer
8
medical association
8
cancer control
8
canadian society
8
society control
8
control cancer
8
voluntary cancer
8
king george
8

Similar Publications

Introduction: A long-term engagement (LTE) intervention was embedded in a social marketing campaign aimed at motivating quit attempts among Canadian adult commercial tobacco users 35 to 64 years of age. The purpose of this study was to examine the effectiveness and appeal of LTE within a marketing campaign.

Methods: 3,199 Canadians who smoked cigarettes aged 35-64 recruited using Facebook and Instagram advertisements were randomized into Intervention and Control groups.

View Article and Find Full Text PDF

[Epidemiology and prevention of oropharyngeal cancer : Summary of the new German S3 guideline].

HNO

January 2025

Klinik und Poliklinik für Hals‑, Nasen‑, Ohrenheilkunde, Universitätsklinikum Leipzig, Universität Leipzig, Liebigstraße 10, 04103, Leipzig, Deutschland.

Due to the association with the causal human papillomavirus 16 (HPV16) infection, oropharyngeal squamous cell carcinoma is now separated into two distinct entities depending on HPV16 positivity. More recent data show a diversified picture of the importance and prevalence of the surrogate parameter p16 (discordance) for a definitive HPV16 association, which varies worldwide. In the context of preventive options, vaccination is of major importance and HPV screening of healthy people of less importance.

View Article and Find Full Text PDF

Globally, an estimated 300 million individuals have sickle cell trait (SCT), the carrier state for sickle cell disease. While sickle cell disease (SCD) is associated with increased morbidity and shortened lifespan, SCT has a lifespan comparable to that of the general population. However, "sickle cell crisis" has been used as a cause of death for decedents with SCT in reports of exertion-related death in athletes, military personnel, and individuals in police custody.

View Article and Find Full Text PDF

Background And Objective: PARP inhibitor (PARPi) treatment is an effective option for patients with metastatic castration-resistant prostate cancer (mCRPC). There are few data on the cardiovascular and thromboembolic safety of these agents in mCRPC, as cardiovascular and thromboembolic adverse events (AEs) are uncommon. Our aim was to analyze the incidence and risk of major adverse cardiovascular events (MACEs), thromboembolic events, and hypertension with PARPi therapy in mCRPC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!